Markets › United States › NAS › ACAD

ACADIA Pharmaceuticals Inc

NAS:ACADHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$20.44+3.23%At closeAt close · Wed 21 Oct · ≈ AED 75.07 · Market cap $3.52B · Next earnings Wed 4 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	95.3%	96.0%	98.0%	93.7%	91.5%	91.7%	—	—
Operating margin	−64.9%	−35.2%	−43.2%	−10.1%	24.1%	9.8%	9.8%	+0.0 pts
Net margin	−63.7%	−34.7%	−41.8%	−8.4%	23.6%	36.5%	36.5%	+0.0 pts
EBITDA margin	−64.2%	−33.9%	−40.9%	−6.3%	10.5%	14.1%	—	—
Return on equity	−44.9%	−31.0%	−53.9%	−14.2%	30.9%	31.9%	31.9%	+0.0 pts
Return on assets	−36.0%	−24.0%	−36.7%	−8.2%	19.1%	25.0%	25.0%	+0.0 pts
Return on capital employed	−42.4%	−28.2%	−48.4%	−14.8%	29.1%	8.1%	—	—
Debt / equity	0.1×	0.1×	0.2×	0.1×	0.1×	0.0×	0.0×	+0.0%
Debt / assets	6.3%	9.2%	10.5%	7.6%	4.4%	3.3%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	6.8×	6.4×	4.0×	2.4×	2.4×	3.8×	3.8×	+0.0%
Quick ratio	6.7×	6.3×	4.0×	2.3×	2.3×	3.7×	—	—
Cash ratio	3.1×	1.5×	0.9×	0.7×	0.8×	0.6×	0.6×	+0.0%
Asset turnover	0.6×	0.7×	0.9×	1.0×	0.8×	0.7×	—	—
Inventory turnover	2.1×	2.4×	1.5×	1.3×	3.7×	2.6×	—	—
Receivables turnover	8.8×	7.4×	8.2×	7.1×	9.1×	7.2×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—